imiquimod has been researched along with beta-escin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hennessy, T; Hook, S; McBurney, WT; Myschik, J; Rades, T | 1 |
| Kim, S; Lim, YT; Noh, HJ; Noh, YW; Shin, WJ; Um, SH | 1 |
| Feng, F; Feng, Z; Lyu, R; Ma, T | 1 |
| Duan, Q; Kang, T; Liu, M; Naqvi, S; Wang, Z; Xiao, S; Zhang, F; Zhang, G; Zheng, Y | 1 |
| Di, T; Fu, J; Guo, J; Guo, X; Li, P; Liu, Q; Liu, Y; Meng, Y; Qi, C; Wang, Y; Zhang, L; Zhao, J | 1 |
5 other study(ies) available for imiquimod and beta-escin
| Article | Year |
|---|---|
Immunogenicity of lipid sustained release implants containing imiquimod, alpha-galactosylceramide, or Quil-A.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Delayed-Action Preparations; Drug Carriers; Drug Implants; Epitopes; Flow Cytometry; Galactosylceramides; Imiquimod; Immunization; Immunoglobulin G; Lipids; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Organisms, Genetically Modified; Ovalbumin; Quillaja Saponins; Saponins; Vaccines | 2008 |
Hyaluronic acid-supported combination of water insoluble immunostimulatory compounds for anti-cancer immunotherapy.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cancer Vaccines; Drug Carriers; Female; Hyaluronic Acid; Hydrogen Bonding; Imiquimod; Immunotherapy; Lipid A; Lymphoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Saponins; Solubility | 2017 |
[Esculentoside reduces expression of Th17 cell-related cytokines in the imiquimod-induced psoriasis-like dermatitis mouse model].
Topics: Animals; Cytokines; Dermatitis; Female; Imiquimod; Mice; Mice, Inbred BALB C; Oleanolic Acid; Psoriasis; Random Allocation; Saponins; Skin; Th17 Cells | 2019 |
Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-κB pathway.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Humans; Imiquimod; Immunosuppression Therapy; Inflammation; Keratinocytes; Mice; NF-kappa B; Oleanolic Acid; Reactive Oxygen Species; Saponins; Signal Transduction | 2020 |
Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells.
Topics: Animals; Cell Proliferation; Cytokines; Dendritic Cells; Disease Models, Animal; Imiquimod; Mice; Mice, Inbred BALB C; Psoriasis; Saponins; Skin; Substance P | 2022 |